Tag: Cancer: Uterine

Findings seen in combination with chemotherapy following surgery in patients with curative intent

Study reveals objective response rate of 22 percent and clinical benefit rate of 32 percent

Significant proportion of those with EC have endometrial thickness below the range of diagnostic threshold for detection on ultrasound

Significant reductions in disease progression or death seen with both mismatch repair-proficient and -deficient cases

Among postmenopausal women, moderate and heavy use associated with increased risk versus never/light use

Findings seen for maintenance therapy in patients with advanced or recurrent disease following response to systemic therapy

Caribbean Black women have lowest rates of endometrioid and nonendometrioid subtypes

Dostarlimab plus carboplatin-paclitaxel linked to increased progression-free survival overall and in dMMR-MSI-H population

Addition of pembrolizumab to paclitaxel plus carboplatin yields longer progression-free survival in advanced, recurrent disease

Improvement seen in severe pain, anxiety for treatment groups receiving preoperative touch/relaxation with or without intraoperative acupuncture